ArticleBMC gastroenterology2025

Therapeutic regimen of Crohn's disease: effect of Infliximab combined with mesalazine on intestinal flora and inflammatory indexes in patients.

Xiaoxia Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.